Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of March 31, 2025 • 4:41 PM ET

Date/Time Source News Release
03/28/2025 08:00 AM EDT GlobeNewswire Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity
03/11/2025 08:00 AM EDT GlobeNewswire Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update
02/25/2025 08:00 AM EST GlobeNewswire Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences
02/14/2025 07:30 AM EST GlobeNewswire CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025
02/11/2025 07:30 AM EST GlobeNewswire Corbus Pharmaceuticals Announces Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at 2025 ASCO-GU
01/28/2025 08:00 AM EST GlobeNewswire Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech Conference
01/08/2025 08:00 AM EST GlobeNewswire Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025
01/06/2025 08:00 AM EST GlobeNewswire Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
12/09/2024 07:00 AM EST GlobeNewswire Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors
12/03/2024 07:00 AM EST GlobeNewswire FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer
Page

Additional News

As of March 31, 2025 • 4:41 PM ET

Date/Time Source News Release
03/20/2025 09:35 AM EDT Zacks After Plunging -22.69% in 4 Weeks, Here's Why the Trend Might Reverse for Corbus Pharmaceuticals (CRBP)
03/19/2025 09:35 AM EDT Zacks After Plunging -22.9% in 4 Weeks, Here's Why the Trend Might Reverse for Corbus Pharmaceuticals (CRBP)
03/14/2025 01:58 PM EDT Stock Traders Daily (CRBP) Investment Analysis and Advice
03/13/2025 12:00 PM EDT Zacks Corbus Pharmaceuticals (CRBP) Upgraded to Buy: Here's What You Should Know
03/11/2025 08:14 AM EDT SeekingAlpha Corbus Pharmaceuticals GAAP EPS of -$0.78 beats by $0.50
03/11/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, March 11th, 2025
03/11/2025 05:31 AM EDT US Earnings Reports Expected earnings - Corbus Pharmaceuticals Holdings Inc.
03/03/2025 09:26 PM EST Stock Traders Daily When (CRBP) Moves Investors should Listen
02/14/2025 09:08 AM EST SeekingAlpha Corbus Pharmaceuticals falls after trial data for lead asset
01/09/2025 01:32 AM EST Stock Traders Daily (CRBP) Investment Analysis
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.